Sort   by:  
 Page size 
UnknownDescription of a novel SLC34A3.c.671delT mutation causing hereditary hypophosphatemic rickets with hypercalciuria in two adolescent boys and response to recombinant human growth hormone.
Not available
S-EPMC7488884 | biostudies-literature
UnknownHistiocytosis Presenting as Bilateral Adrenal Masses: A Case Report.
Not available
S-EPMC10766400 | biostudies-literature
UnknownCase Studies in Pediatric Endocrinology: An Interactive Learning Module.
Not available
S-EPMC6464428 | biostudies-literature
UnknownAdverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study.
Not available
S-EPMC9306877 | biostudies-literature
UnknownTreatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial.
Not available
S-EPMC10997502 | biostudies-literature
UnknownDasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006).
Not available
S-EPMC4365700 | biostudies-literature
UnknownFactors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis.
Not available
S-EPMC12505080 | biostudies-literature
UnknownIFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia.
Not available
S-EPMC9433106 | biostudies-literature
UnknownIncreased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.
Not available
S-EPMC5420794 | biostudies-literature
UnknownA clinical trial to maintain glycemic control in youth with type 2 diabetes.
Not available
S-EPMC3478667 | biostudies-literature
Sort   by:  
 Page size